🔒 Encrypted & handled per our Privacy Policy
Meeting these guidelines does not mean you have a valid claim. It means a participating law firm is likely to review it. That firm decides on its own whether to take your case. Some claims are turned down, and some recover nothing. Direct2Attorney cannot judge the legal merits of your case, give legal advice, or file anything for you.
Almost no one can. These cases were never built on receipts. What matters is how often and how long, and that comes from you and the people who knew you. A free review takes about two minutes.
— Educational
Chemical relaxers straighten hair by breaking the bonds that give it curl. Doing that takes harsh chemistry — usually lye or a lye substitute, applied directly to the scalp and left there until the hair gives.
The scalp is not like the rest of your skin. It absorbs more, and relaxers frequently caused burns, sores and open cuts. That gave the chemicals a direct route into the body, over and over, for years.
Testing has found endocrine-disrupting chemicals in these products. That includes phthalates, parabens and, in some formulas, formaldehyde or chemicals that release it. Endocrine disruptors interfere with hormones. The cancers in this litigation — uterine, endometrial and ovarian — are hormone-driven.
These products were marketed overwhelmingly to Black women and girls, often from early childhood. The lawsuits allege the manufacturers knew about the risks and never put a warning on the box.
Researchers at the National Institutes of Health followed tens of thousands of women over years. Those who used chemical straighteners frequently — more than four times a year — had roughly double the risk of uterine cancer compared with women who never used them.
That study is the reason this litigation exists. It is also why cases kept getting filed after it was published.
Studies like this report patterns across large groups of people. They are strong evidence of an association. They do not prove what caused any one woman’s cancer.
The manufacturers dispute causation entirely. Proving its case by case is the central fight in this litigation, and it is happening right now.
Cases are consolidated as MDL 3060 before Judge Mary M. Rowland in the Northern District of Illinois. As of July 1, 2026 there were 11,877 cases pending, making it one of the largest MDLs in the country, with roughly 150 added in June alone. Defendants include L’Oréal, SoftSheen-Carson, Revlon and other manufacturers. In April 2026 Judge Rowland scrapped the system where each side took turns picking test cases and selected 10 herself — more than the three originally planned. Additional cases are also being filed in state courts in Philadelphia, Atlanta and New York.
Before any trial happens, the court has to decide whether the plaintiffs’ scientific experts may testify at all. This is called a Daubert ruling. Argument is expected late in 2026 and a decision in early 2027. If the court excludes the plaintiffs’ causation experts, this litigation could largely collapse. That is not a scare tactic — it happened in the Tylenol autism MDL, which ended without a single trial after the experts were thrown out. First trials here are expected around mid-2027, and no global settlement has been announced. A court-appointed special master is overseeing settlement talks.
The most common early sign of uterine cancer is abnormal vaginal bleeding — bleeding between periods, unusually heavy periods, or any bleeding after menopause. Post-menopausal bleeding is never normal and should always be checked. Uterine cancer is highly treatable when it is caught early. If you have used relaxers for years and notice bleeding, pelvic pain or unusual discharge, see a gynecologist. That matters more than any lawsuit. This page is general information and not medical advice.
— Compensation
If a claim succeeds, compensation is meant to cover what the illness has cost you — in money, in work, and in life. Here is what these claims typically seek.
— The process
You do not need brand names, receipts or records to start. Tell us what you remember and the firm does the rest.
Fill out the short form or call. Roughly how often you used relaxers, for how many years, and what you were diagnosed with. It takes about two minutes and costs nothing.
If your situation fits, we connect you with a participating law firm. That firm looks at your case on its own and decides whether to represent you. If it does, you sign an agreement directly with the firm.
Medical and pathology records, plus statements from you and the people who did your hair or grew up with you. In these cases, lay witnesses matter more than paperwork.
Your case is filed and coordinated in MDL 3060 or an appropriate state court. Your firm keeps you updated as the science rulings and first trials approach. You are never required to accept an offer you do not want.
💰
⚖️
💬
What Direct2Attorney is
A legal marketing and referral service. We check whether your situation matches what participating law firms are looking for, and connect you with one of them if it does.
What Direct2Attorney is not
We are not a law firm. We cannot give you legal advice, represent you, or file anything on your behalf. Only a law firm you sign with can do that.
If you used chemical relaxers for years and were later diagnosed with uterine, endometrial or ovarian cancer, find out where you stand. You do not need brand names or receipts. It takes about two minutes, it costs nothing, and your state’s filing deadline is running whether or not you look into it.
Participating law firms are generally reviewing claims from women who used chemical hair relaxers or straighteners regularly, about four or more times a year over several years, and were later diagnosed with uterine cancer, endometrial cancer or ovarian cancer. Salon use and at-home use both count. Family members may be able to bring a wrongful death claim for a loved one who died.
Yes. Almost nobody remembers brand names from twenty or thirty years ago, and the courts know that. These cases are built differently from drug cases. There are no pharmacy records, so what matters is your use history, and that can be established through your own account, family members who did your hair or saw you use it, and salon records where they still exist.
A 2022 study by the National Institutes of Health followed tens of thousands of women and reported that those who used chemical straighteners frequently, more than four times a year, had roughly double the risk of uterine cancer compared with women who did not use them. Other research has looked at similar questions. Studies like these report associations across large groups. They do not by themselves prove what caused any one woman’s cancer, and the manufacturers dispute causation.
Not soon. The first bellwether trials are expected around the middle of 2027. Before that, the court has to rule on whether the plaintiffs’ scientific experts can testify at all, with argument expected late in 2026 and a decision expected in early 2027. No global settlement has been announced. A court-appointed special master is overseeing settlement discussions.
Those claims exist in the litigation, but be aware of an important difference. The cases the court selected for the first trials are limited to uterine, endometrial and ovarian cancer claims. That makes cancer claims the strongest right now. A fibroid or endometriosis claim may still be reviewed, but it sits outside the trial track.
Nothing to ask. The case review is free with no obligation. If a participating law firm takes your case, it will normally work on contingency. That means the fee comes out of a recovery, and no fee is owed if there is no recovery.
No. Direct2Attorney is a legal marketing and referral service, not a law firm. An attorney-client relationship may form only after a participating law firm reviews your information and signs a separate representation agreement with you.
Ask it on the call. The review is free, and there is no obligation to move forward.
— News & updates
As 2026 begins, hair relaxer lawsuits are gaining renewed attention. What started as limited concern over hormone disruption has now
Hair relaxer product warning lawsuits 2026 are becoming a major legal focus as new science raises concerns about whether consumers
Were you diagnosed with uterine or ovarian cancer after using hair relaxers? Learn how victims are filing lawsuits and what
Hair Relaxer Lawsuit 2025 now includes over 10,000 claims linking relaxers to cancer. The MDL is expanding, with bellwether trials
The Fight Against Cancer Risks and Corporate Negligence in Hair Relaxer Products The Hair Relaxer Crisis Chemical hair relaxers, marketed
